The Pacific Accounting Review has selected a paper by BioPacific team members Sujit Kalidas and Dr Andrew Kelly as a Highly Commended Paper of 2014. Titled “New Zealand Venture Capital funds and access to new financing: An exploratory study” the study explored challenges that the venture capital (VC) funds industry in New Zealand faces when sourcing new capital.
It was chosen as a Highly Commended Paper as “it is one of the most impressive pieces of work the team has seen throughout 2014,” said Jim Bowden of Emerald Group Publishing.
Congratulations to Andrew and Sujit on this acknowledgement of their contribution to the industry.
You can access this paper here.